The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biomarker-Global Market Insights and Sales Trends 2024
Synopsis
Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker is "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention."
The global Biomarker market size is expected to reach US$ 68010 million by 2029, growing at a CAGR of 12.7% from 2023 to 2029. The market is mainly driven by the significant applications of Biomarker in various end use industries. The expanding demands from the Diagnostics Development, Drug Discovery and Development, Disease-Risk and Other, are propelling Biomarker market. Consumables, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Service segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Biomarker market, driven by demand from China, the second largest economy with some signs of stabilising, the Biomarker market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biomarker, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biomarker market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biomarker market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biomarker sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biomarker covered in this report include F. Hoffmann-La Roche Ltd., Abbott, Epigenomics AG, General Electric, Johnson & Johnson Services, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH and QIAGEN, etc.
The global Biomarker market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
F. Hoffmann-La Roche Ltd.
Abbott
Epigenomics AG
General Electric
Johnson & Johnson Services, Inc.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Siemens Healthcare GmbH
QIAGEN
Global Biomarker market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biomarker market, Segment by Type:
Consumables
Service
Global Biomarker market, by Application
Diagnostics Development
Drug Discovery and Development
Disease-Risk
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biomarker companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker is "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention."
The global Biomarker market size is expected to reach US$ 68010 million by 2029, growing at a CAGR of 12.7% from 2023 to 2029. The market is mainly driven by the significant applications of Biomarker in various end use industries. The expanding demands from the Diagnostics Development, Drug Discovery and Development, Disease-Risk and Other, are propelling Biomarker market. Consumables, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Service segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Biomarker market, driven by demand from China, the second largest economy with some signs of stabilising, the Biomarker market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biomarker, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biomarker market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biomarker market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biomarker sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biomarker covered in this report include F. Hoffmann-La Roche Ltd., Abbott, Epigenomics AG, General Electric, Johnson & Johnson Services, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH and QIAGEN, etc.
The global Biomarker market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
F. Hoffmann-La Roche Ltd.
Abbott
Epigenomics AG
General Electric
Johnson & Johnson Services, Inc.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Siemens Healthcare GmbH
QIAGEN
Global Biomarker market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biomarker market, Segment by Type:
Consumables
Service
Global Biomarker market, by Application
Diagnostics Development
Drug Discovery and Development
Disease-Risk
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biomarker companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biomarker
1.1 Biomarker Market Overview
1.1.1 Biomarker Product Scope
1.1.2 Biomarker Market Status and Outlook
1.2 Global Biomarker Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biomarker Market Size by Region (2018-2029)
1.4 Global Biomarker Historic Market Size by Region (2018-2023)
1.5 Global Biomarker Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biomarker Market Size (2018-2029)
1.6.1 North America Biomarker Market Size (2018-2029)
1.6.2 Europe Biomarker Market Size (2018-2029)
1.6.3 Asia-Pacific Biomarker Market Size (2018-2029)
1.6.4 Latin America Biomarker Market Size (2018-2029)
1.6.5 Middle East & Africa Biomarker Market Size (2018-2029)
2 Biomarker Market by Type
2.1 Introduction
2.1.1 Consumables
2.1.2 Service
2.2 Global Biomarker Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biomarker Historic Market Size by Type (2018-2023)
2.2.2 Global Biomarker Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biomarker Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biomarker Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biomarker Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biomarker Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biomarker Revenue Breakdown by Type (2018-2029)
3 Biomarker Market Overview by Application
3.1 Introduction
3.1.1 Diagnostics Development
3.1.2 Drug Discovery and Development
3.1.3 Disease-Risk
3.1.4 Other
3.2 Global Biomarker Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biomarker Historic Market Size by Application (2018-2023)
3.2.2 Global Biomarker Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biomarker Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biomarker Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biomarker Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biomarker Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biomarker Revenue Breakdown by Application (2018-2029)
4 Biomarker Competition Analysis by Players
4.1 Global Biomarker Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biomarker as of 2022)
4.3 Date of Key Players Enter into Biomarker Market
4.4 Global Top Players Biomarker Headquarters and Area Served
4.5 Key Players Biomarker Product Solution and Service
4.6 Competitive Status
4.6.1 Biomarker Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 F. Hoffmann-La Roche Ltd.
5.1.1 F. Hoffmann-La Roche Ltd. Profile
5.1.2 F. Hoffmann-La Roche Ltd. Main Business
5.1.3 F. Hoffmann-La Roche Ltd. Biomarker Products, Services and Solutions
5.1.4 F. Hoffmann-La Roche Ltd. Biomarker Revenue (US$ Million) & (2018-2023)
5.1.5 F. Hoffmann-La Roche Ltd. Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Biomarker Products, Services and Solutions
5.2.4 Abbott Biomarker Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Epigenomics AG
5.3.1 Epigenomics AG Profile
5.3.2 Epigenomics AG Main Business
5.3.3 Epigenomics AG Biomarker Products, Services and Solutions
5.3.4 Epigenomics AG Biomarker Revenue (US$ Million) & (2018-2023)
5.3.5 General Electric Recent Developments
5.4 General Electric
5.4.1 General Electric Profile
5.4.2 General Electric Main Business
5.4.3 General Electric Biomarker Products, Services and Solutions
5.4.4 General Electric Biomarker Revenue (US$ Million) & (2018-2023)
5.4.5 General Electric Recent Developments
5.5 Johnson & Johnson Services, Inc.
5.5.1 Johnson & Johnson Services, Inc. Profile
5.5.2 Johnson & Johnson Services, Inc. Main Business
5.5.3 Johnson & Johnson Services, Inc. Biomarker Products, Services and Solutions
5.5.4 Johnson & Johnson Services, Inc. Biomarker Revenue (US$ Million) & (2018-2023)
5.5.5 Johnson & Johnson Services, Inc. Recent Developments
5.6 Thermo Fisher Scientific Inc.
5.6.1 Thermo Fisher Scientific Inc. Profile
5.6.2 Thermo Fisher Scientific Inc. Main Business
5.6.3 Thermo Fisher Scientific Inc. Biomarker Products, Services and Solutions
5.6.4 Thermo Fisher Scientific Inc. Biomarker Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific Inc. Recent Developments
5.7 Bio-Rad Laboratories, Inc.
5.7.1 Bio-Rad Laboratories, Inc. Profile
5.7.2 Bio-Rad Laboratories, Inc. Main Business
5.7.3 Bio-Rad Laboratories, Inc. Biomarker Products, Services and Solutions
5.7.4 Bio-Rad Laboratories, Inc. Biomarker Revenue (US$ Million) & (2018-2023)
5.7.5 Bio-Rad Laboratories, Inc. Recent Developments
5.8 Siemens Healthcare GmbH
5.8.1 Siemens Healthcare GmbH Profile
5.8.2 Siemens Healthcare GmbH Main Business
5.8.3 Siemens Healthcare GmbH Biomarker Products, Services and Solutions
5.8.4 Siemens Healthcare GmbH Biomarker Revenue (US$ Million) & (2018-2023)
5.8.5 Siemens Healthcare GmbH Recent Developments
5.9 QIAGEN
5.9.1 QIAGEN Profile
5.9.2 QIAGEN Main Business
5.9.3 QIAGEN Biomarker Products, Services and Solutions
5.9.4 QIAGEN Biomarker Revenue (US$ Million) & (2018-2023)
5.9.5 QIAGEN Recent Developments
6 North America
6.1 North America Biomarker Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Biomarker Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biomarker Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biomarker Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biomarker Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biomarker Market Dynamics
11.1 Biomarker Industry Trends
11.2 Biomarker Market Drivers
11.3 Biomarker Market Challenges
11.4 Biomarker Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
